Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides
Fortune Journal of Health Sciences · 2026 · 9 (4)
DOI: 10.26502/fjhs.452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Stephen Hsu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hsu, S., Yu, H., Philip, A., Mouna, A., Sarker, A. K., Marshall, B., & Dickinson, D. (2026). Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides. Fortune Journal of Health Sciences, 9(4). https://doi.org/10.26502/fjhs.452
Vancouver
Hsu S, Yu H, Philip A, Mouna A, Sarker AK, Marshall B, et al. Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides. Fortune Journal of Health Sciences. 2026;9(4). doi:10.26502/fjhs.452
BibTeX
@article{Hsu2026,
author = {Hsu, Stephen and Yu, Hongfang and Philip, Archith and Mouna, Amani and Sarker, Ashish K. and Marshall, Brendan and Dickinson, Douglas},
title = {Overcoming Formulation Challenges Across Molecular Classes: Rapid FAST Nanoformulation of BCS Class II/IV Drugs and Therapeutic Peptides},
journal = {Fortune Journal of Health Sciences},
year = {2026},
volume = {9},
number = {4},
doi = {10.26502/fjhs.452}
}
EUVIMED